The Centers for Disease Control and Prevention is now tracking several new variants of COVID-19, the firm said Friday, adding more Omicron descendants to an increasingly complex list of new strains competing nationally.
Among the new variants recently tracked through the CDC is EU. 1. 1, a strain first designated by scientists before this year of its immediate rise in some European countries.
The variant is a more remote descendant of the XBB. 1. 5 variant that emerged earlier this year, with a handful of additional mutations in its spike protein that may be causing it to spread.
The CDC estimates that EU. 1. 1 now accounts for 1. 7% of U. S. cases. It is in the U. S. nationally, but may have already reached 8. 7% of cases in the region covering Colorado, Montana, North Dakota, South Dakota, Utah and Wyoming.
It is too early to know that EU. 1. 1 will cause new or other symptoms in the US. U. S.
Despite some anecdotal reports, fitness officials said there is little evidence of past variants leading to adjustments in the effects of COVID-19. Changes over time in the underlying immunity of other inflamed people can have an effect on how other people are affected by the virus. , extra-blurry reports of symptom settings.
It is now estimated that all Americans have antibodies from a vaccine, at least one infection, or a combination of both. A growing percentage of hospitalizations and deaths are now due to reinfections, the CDC reported Thursday.
Utah laboratories sequenced the maximum number of EU. 1. 1 infections of any state, with approximately one hundred cases of EU. 1. 1 reported through the state’s public fitness laboratory to global virus databases.
In contrast, labs in neighboring Nevada and Colorado reported single-digit numbers of infections sequenced EU. 1. 1.
However, overall COVID-19 trends in Utah lately resemble those in the rest of the country, which lately hovers around the record levels seen in the late spring and summer months.
A consortium of educational and federal modelers recently predicted that the U. S. will most likely be able to do so. U. S. stocks will continue to see pauses in COVID-19 hospitalizations and deaths in the warmer months of at least the next two years, with upcoming peaks in fall and winter likely to no more than past ones. Records. .
The speed of new hospital admissions and emergency room visits for COVID-19 in Utah has greatly slowed or stabilized in recent months, according to CDC figures.
Most national variants are still grouped through the CDC into one of the 4 XBB group strains of relatives of SARS-CoV-2 variants.
The maximum is XBB. 1. 5, which has fallen to 27. 0% of infections. Another is XBB. 1. 9. 2 and XBB. 1. 9. 1, which combined account for 24. 4% of cases. XBB. 1. 16 is the maximum Array time with 19. 9% virus in circulation. Below them is XBB. 2. 3, with 10. 6% nationally.
The Food and Drug Administration ruled earlier this month that COVID-19 vaccines this fall will be revised to target the XBB. 1. 5 variant. But officials say all of those strains, along with a host of their direct descendants, appear to be so strongly connected that new vaccines will expand immunity for everyone.
Moderna announced Thursday that it has officially finalized its application for emergency use authorization of its recently revised plans for the fall.
Although officially designed to target XBB. 1. 5, the drugmaker touted studies suggesting its new vaccine would offer effective “robust human immune responses” to also oppose its relatives XBB. 1. 16 and XBB. 2. 3.